| Aaron Cates, PT | |
|
1879 Portola Rd Ste A2, Ventura, CA 93003-8095 | |
| (805) 644-1273 | |
| Not Available |
| Full Name | Aaron Cates |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 1879 Portola Rd Ste A2, Ventura, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033521893 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 38611 (California) | Secondary |
| 225100000X | Physical Therapist | 62 036836 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aaron Cates, PT 1879 Portola Rd Ste A2, Ventura, CA 93003-8095 Ph: (805) 644-1273 | Aaron Cates, PT 1879 Portola Rd Ste A2, Ventura, CA 93003-8095 Ph: (805) 644-1273 |
News Archive
Today's headlines include a report about how the delay of the health law's employer mandate might undermine enforcement of the measure's individual mandate as well as news that the House will consider a bill that would put off both of these provisions.
New study results found that guideline-directed medical treatment is as effective as invasive procedures, such as coronary stenting, at preventing heart attack, stroke, and death in patients with stable coronary artery disease.
How did China and Australia develop and produce swine flu vaccine months before North America and Europe? A panel of U.S. experts will try to answer this question and report on other comparative findings in a workshop at the National Science Foundation in Arlington, VA, on May 5, 2010.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, provides an update on its business performance for 2014. MGB Biopharma is developing a pipeline of novel antimicrobials that puts it at the forefront of addressing the major global problem of antimicrobial resistance.
› Verified 9 days ago
Sarah Kathleen Wallington, PT, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3418 Loma Vista Rd, Ventura, CA 93003 Phone: 805-765-4773 | |
Sahar Vafadar, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2189 Eastman Ave, Ventura, CA 93003 Phone: 805-639-2600 | |
Mrs. Deborah Smith, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3737 Telegraph Rd, Suite A, Ventura, CA 93003 Phone: 805-642-4678 Fax: 805-642-2038 | |
Mr. Samuel Fisher, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3737 Telegraph Rd, Ste A, Ventura, CA 93003 Phone: 805-642-4678 Fax: 805-642-2038 | |
San Buenaventura Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2807 Loma Vista Rd, Suite 104, Ventura, CA 93003 Phone: 805-216-8889 | |
Janelle M Johnson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3525 Loma Vista Rd, Ste A, Ventura, CA 93003 Phone: 805-644-6424 Fax: 805-641-6415 |